Whales with a lot of money to spend have taken a noticeably bearish stance on Bristol-Myers Squibb.
Looking at options history for Bristol-Myers Squibb BMY we detected 26 trades.
If we consider the specifics of each trade, it is accurate to state that 34% of the investors opened trades with bullish expectations and 61% with bearish.
From the overall spotted trades, 9 are puts, for a total amount of $407,249 and 17, calls, for a total amount of $1,998,519.
Projected Price Targets
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $50.0 to $65.0 for Bristol-Myers Squibb during the past quarter.
Volume & Open Interest Trends
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Bristol-Myers Squibb's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Bristol-Myers Squibb's significant trades, within a strike price range of $50.0 to $65.0, over the past month.
Bristol-Myers Squibb Option Activity Analysis: Last 30 Days
Biggest Options Spotted:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BMY | CALL | TRADE | NEUTRAL | 01/16/26 | $6.95 | $6.75 | $6.85 | $55.00 | $510.3K | 8.7K | 801 |
| BMY | CALL | SWEEP | BULLISH | 03/21/25 | $3.6 | $3.55 | $3.6 | $55.00 | $360.1K | 12.3K | 1.0K |
| BMY | CALL | SWEEP | BULLISH | 03/21/25 | $4.0 | $3.95 | $4.0 | $55.00 | $263.2K | 12.3K | 1.6K |
| BMY | CALL | SWEEP | BULLISH | 05/16/25 | $6.55 | $6.4 | $6.55 | $52.50 | $149.3K | 1.9K | 229 |
| BMY | CALL | SWEEP | BULLISH | 03/21/25 | $4.0 | $3.95 | $4.0 | $55.00 | $136.8K | 12.3K | 2.0K |
About Bristol-Myers Squibb
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
In light of the recent options history for Bristol-Myers Squibb, it's now appropriate to focus on the company itself. We aim to explore its current performance.
Where Is Bristol-Myers Squibb Standing Right Now?
- Trading volume stands at 4,648,166, with BMY's price up by 1.13%, positioned at $56.92.
- RSI indicators show the stock to be is currently neutral between overbought and oversold.
- Earnings announcement expected in 16 days.
Professional Analyst Ratings for Bristol-Myers Squibb
Over the past month, 1 industry analysts have shared their insights on this stock, proposing an average target price of $65.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. Click here for access. * An analyst from Truist Securities persists with their Buy rating on Bristol-Myers Squibb, maintaining a target price of $65.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Bristol-Myers Squibb options trades with real-time alerts from Benzinga Pro.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
